Alerts
PDF
Other content recommended for you
- “Two per cent isn’t a lot, but when it comes to death it seems quite a lot anyway”: patients’ perception of risk and willingness to accept risks associated with thrombolytic drug treatment for acute stroke
- Thrombolysis for acute ischaemic stroke: consumer involvement in design of new randomised controlled trial
- OPtimising Treatment for MIld Systolic hypertension in the Elderly (OPTiMISE): protocol for a randomised controlled non-inferiority trial
- Potential for quality improvement of acute stroke management in a district general hospital
- Patients' experiences of intervention trials on the treatment of myocardial infarction: is it time to adjust the informed consent procedure to the patient's capacity?
- Medical research in clinical emergency settings in Europe
- ESCAPS study protocol: a feasibility randomised controlled trial of ‘Early electrical stimulation to the wrist extensors and wrist flexors to prevent the post-stroke complications of pain and contractures in the paretic arm’
- Learning from stakeholders to inform good practice guidance on consent to research in intensive care units: a mixed-methods study
- Discussing surgical innovation with patients: a qualitative study of surgeons’ and governance representatives’ views
- Informed consent and participant perceptions of influenza vaccine trials in South Africa